Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8064-8072

  Skraban, Robert ^a   Matthíasdóttir, Sigrídur ^a   Torsteinsdóttir, Sigurbjörg ^a   Agnarsdóttir, Gudrún ^a   Gudmundsson, Bjarki ^a   Georgsson, Gudmundur ^a   Meloen, Rob H ^b   Andrésson, Ólafur S ^a   Staskus, Katherine A ^c   Thormar, Halldor ^a   Andrésdóttir, Valgerdur ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTISERUM; EPITOPE; HYBRID PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; EXPRESSION VECTOR; GENE DELETION; GENE MAPPING; IMMUNOBLOTTING; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS NEUTRALIZATION; VISNA VIRUS;

EID: 0344995290     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8064-8072.1999     Document Type: Article

References (54)

1. Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystrom, and E. M. Fenyo. 1990. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112.
2. Andrésdóttir, V., X. Tang, G. Agnarsdóttir, Ó. S. Andrésson, G. Georgsson, R. Skraban, S. Torsteinsdóttir, B. Rafnar, E. Benediktsdóttir, S. Matthíasdóttir, S. Árnadóttir, S. Högnadóttir, P. A. Pálsson, and G. Pétursson. 1998. Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus. Virus Genes 16:281-293.
3. Andrésdóttir, V., et al. Unpublished results.
4. Andrésson, Ó. S., J. E. Elser, G. J. Tobin. J. D. Greenwood. M. A. Gonda, G. Georgsson, V. Andrésdóttir, E. Benediktsdóttir, H. M. Carlsdóttir, E. O. Mäntylä, B. Rafnar, P. A. Pálsson, J. W. Casey, and G. Pétursson. 1993. Nucleotide sequence and biological properties of a pathogenic proviral mo-lecular clone of neurovirulent visna virus. Virology 193:89-105.
5. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. More, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1988. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
6. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Gianelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
7. Braun, M. J., J. E. Clements, and M. A. Gonda. 1987. The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J. Virol. 61:4046-4054.
8. Choi, W. S., C. Collignon, C. Thiriart, D. P. W. Burns, E. J. Stott, K. A. Kent, and R. C. Desrosiers. 1994. Effects of natural sequence variation on recognition by monoclonal antibodies that neutralize simian immunodeficiency virus infectivity. J. Virol. 68:5395-5402.
9. Cook, R. F., S. L. Berger, K. E. Rushlow, J. M. McManus, S. J. Cook, S. Harrold, M. L. Raabe, R. C. Montelaro, and C. J. Issel. 1995. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope grycoprotein. J. Virol. 69:1493-1499.
10. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. di Marzo Verones, F., M. S. Reitz, G. Gupta, M. Robert-Guroff, C. Boyer-Thompson, A. Louie, R. C. Gallo, and P. Lusso. 1993. Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. J. Biol. Chem. 268:25894-25901.
12. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
13. Gendelman, H. E., O. Narayan, S. Kennedy-Stoskopf, P. G. E. Kennedy, Z. Ghotbi, J. E. Clements, J. Stanley, and G. Pezeshkpour. 1986. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 58:67-74.
14. Georgsson, G., D. J. Houwers, P. A. Pálsson, and G. Pétursson. 1989. Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol. 77:299-306.
15. Georgsson, G. 1990. Maedi-visna: pathology and pathogenesis, p. 19-54. In G. Pétursson and R. Hoff-Jörgensen (ed.). Maedi-visna and related diseases. Kluwer Academic Publishers, Boston, Mass.
16. Geysen, H. M., R. H. Meloen, and S. J. Barteling. 1984. Use of synthetic peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81:3998-4002.
17. Goudsmit, J., C. A. B. Boucher, R. H. Meloen, L. G. Epstein, L. Smit, L. van der Hoek, and M. Bakker. 1988. Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. AIDS 2:157-164.
18. Gudmundsson, B., et al. Unpublished results.
19. Gudnadóttir, M. 1974. Visna-maedi in sheep. Prog. Med. Virol. 18:336-349.
20. Javaherian, K., A. J. Langlois, S. Schmidt, M. Kaufmann, N. Cates, J. P. M. Langedijk, R. H. Meloen, R. C. Desrosiers, D. P. W. Burns, D. P. Bolognesi, G. J. LaRosa, and S. D. Putney. 1992. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 89:1418-1422.
21. Kinsey, N. E., M. G. Anderson, T. J. Unangst, S.V. Joag, O. Narayan, M. C. Zink, and J. E. Clements. 1996. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology 221:14-21.
22. Lasky, L. A., G. Nakamura, and D. J. Smith. 1987. Delineation of a region of a human immunodeficiency virus type 1 gp 120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
23. Lutley, R., G. Pétursson, P. A. Pálsson, G. Georgsson, J. Klein, and N. Nathanson. 1983. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J. Gen. Virol. 64:1433-1440.
24. Lutley, R. E., G. Pétursson, G. Georgsson, P. A. Pálsson, and N. Nathanson. 1985. Strains of visna virus with increased neurovirulence, p. 45-49. In J. M. Sharp and R. Hoff-Jørgensen (ed.), Slow viruses in sheep, goats and cattle. Directorate-General for Agriculture and Coordination of Agricultural Research, Commission of the European Communities, Luxembourg.
25. McKeating, J. A., J. Gow, J. Goudsmit, L. H. Pearl, C. Mulder, and R. A. Weiss. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3:777-784.
26. McKnight, A., R. A. Weiss, C. Shotton, Y. Takeuchi, H. Hoshino, and P. R. Clapham. 1995. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69:3167-3170.
27. Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
28. Nara, P., L. Smit, N. Dunlop, W. Hatch, M. Merges, D. Waters, J. Kelliher, R. C. Gallo, P. J. Fischinger, and J. Goudsmit. 1990. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J. Virol. 64: 3779-3791.
29. Narayan, O., D. E. Griffin, and J. Chase. 1977. Antigenic shift of visna virus in persistently infected sheep. Science 197:376-378.
30. Narayan, O., J. S. Wolinsky, J. E. Clements, J. D. Strandberg, D. E. Griffin, and L. C. Cork. 1982. Slow virus replication: the role of macrophages in the persistence and expression of visna virus in sheep and goats. J. Gen. Virol. 9-345-356.
31. Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to envencoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85:1932-1936.
32. Pancino, G., H. Ellerbrok, M. Sitbon, and P. Sonigo. 1993. Conserved framework of envelope glycoproteins among lentiviruses. Curr. Top. Microbiol. Immun. 188:77-100.
33. Pétursson, G., N. Nathanson, G. Georgsson, H. Panitch, and P. A. Pálsson. 1976. Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab. Investig. 35:402-412.
34. Querat, G., G. Audoly, P. Sonigo, and R. Vigne. 1989. Nucleotide sequence analysis of SA-OMW, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. Virology 175:434-447.
35. Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, A. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fishinger, D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino-acid sequence of the viral envelope gp120. Proc. Natl. Acad. Sci. USA 85:3198-3202.
36. Saltarelli, M., G. Querat, D. A. M. Konings, R. Vigne, and J. E. Clements. 1990. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179:347-364.
37. Sargan, D. R., I. D. Bennet, C. Consens, D. J. Roy, B. A. Blacklaws, R. G. Dalziel, N. J. Watt, and I. McConnell. 1991. Nucleotide sequence of EV1, a British isolate of maedi-visna virus. J. Gen. Virol. 72:1893-1903.
38. Sawyer, L. S. W., M. T. Wrin, L. Crawford-Miksza, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hanson. 1994. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
39. Schreiber, M., C. Wachsmuth, H. Muller, S. Odemuyiwa, H. Schmitz, S. Meyer, B. Meyer, and J. Schnelder-Mergener. 1997. The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain. J. Virol. 71:9198-9205.
40. Siebelink, K. H. J., G. F. Rimmelzwaan, M. L. Bosch, R. H. Meloen, and A. D. M. E. Osterhaus. 1993. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J. Virol. 67:2202-2208.
41. Siebelink, K. H. J., W. Huisman, J. A. Karlas, G. F. Rimmelzwaan, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J. Virol. 69:5124-5127.
42. Sigurdsson, B., H. Grimsson, and P. A. Palsson. 1952. Maedi, a chronic, progressive infection of sheep's lungs. J. Infect. Dis. 90:233-241.
43. Sigurdsson, B., and P. A. Palsson. 1958. Visna of sheep. A slow demyelinating infection. Br. J. Exp. Pathol. 39:519-528.
44. Sigurdsson, B., H. Thormar, and P. A. Pálsson. 1960. Cultivation of visna virus in tissue culture. Arch. Gesamte Virusforsch. 10:368-380.
45. Sonigo, P., M. Alizon, K. Staskus, D. Klatzmann, S. Cole, O. Danos, E. Retzel, P. Tiollais, A. Haase, and S. Wain-Hobson. 1985. Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell 42:369-381
46. Staskus, K. A., E. F. Retzel, E. D. Lewis, J. L. Silsby, S. St. Cyr, J. M. Rank, S. W. Wietgrefe, A. T. Haase, R. Cook, D. Fast, P. Gieser, J. T. Harty, S. H. Kong, C. J. Lahti, T. P. Neufeld, T. E. Porter, E. Shoop, and K. R. Zachow. 1991. Isolation of replication-competent molecular clones of visna virus. Virology 181:228-240.
47. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp 120-CD4 binding. J. Viral. 67:3978-3988.
48. Thormar, H., M. R Barshatzky, K. Arnesen, and P. B. Kozlowski. 1983. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo. J. Gen. Virol. 64:1427-1432.
49. Torsteinsdottir, S., G. Agnarsdottir, S. Matthiasdottir, B. Rafnar, V. Andresdottir, O. S. Andresson, K. Staskus, G. Petursson, P. A. Palsson, and G. Georgsson. 1997. In vivo and in vitro infection with two different molecular clones of visna virus. Virology 229:370-380.
50. Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp 120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
51. Turelli, P., G. Pétursson, F. Guiguen, J.-F. Mornex, R. Vigne, and G. Querat. 1996. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70:1213-1217.
52. Verschoor, E. J., L. A. Boven, H. Blaak, A. I. W. Van Vliet, M. C. Horzinek, and A. de Ronde. 1995. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 69:4752-4757.
53. Wolfs, T. F. W., G. Zwart, M. Bakker, M. Valk, C. L. Kuiken, and J. Goudsmit. 1991. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 185:195-205.
54. Zhuge, W., F. Jia, I. Adany, O. Narayan, and E. B. Stephens. 1997. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures. Virology 227:24-33.